Werewolf Therapeutics (HOWL)
(Delayed Data from NSDQ)
$3.25 USD
+0.18 (5.86%)
Updated Jun 13, 2024 04:00 PM ET
After-Market: $3.24 -0.01 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Werewolf Therapeutics, Inc. [HOWL]
Reports for Purchase
Showing records 41 - 45 ( 45 total )
Company: Werewolf Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
HOWL Reports 2Q21; Reiterate Buy and Maintain PT at $32
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Werewolf Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
HOWL Reports 1Q21; Updating Model; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Werewolf Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Engineered Cytokines Drawing a Crowd, in a Good Way
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Werewolf Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Modified IL-2 Constructs from Competitors Gain Attention at ASCO
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Werewolf Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage of Werewolf Therapeutics; Cancer?s Worst Nightmare
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department